Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Infectious diseases 13

Infectious Diseases

pharma-biotech-news-updates-for-biogen-pfizer-viiv-calliditas

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Pfizer’s COVID-19 Vaccine; Calliditas’ NefIgArd trial; ViiV’s HIV Prevention Treatment; Biogen’s Aducanumab Rejection

Pfizer's COVID-19 vaccine heralded as the showstopper with over 90% effectiveness Based on the interim data from the Phase III COVID-19 vaccine trial results, the pharma titan, Pfizer, announced that its COVID-19 vaccine is more than 90% effective in preventing coronavirus infection. Tedros Adhanom Ghebreyesus, the World Health Organization (WHO) chief, took to Twitter to address the results as new and encouraging. The duo said there were no serious safety concerns and expected to file for FDA emergency use authorization this month. If granted, they can start rolling out up to 50 million doses this year, enough to provide for 25 million people, and then pr...

Explore More...

Cholera vaccine delivered; Rice-inspired breakthroughs; International partnerships

Novartis signs; Sosei passes; Amgen remunerates; J&J remunerates for RSV drug

Orchard files for IPO; J&J puts money on RNA interference; Rgenix receives $40M; GSK gives a helping hand

Notizia

transthyretin amyloidosis

Notizia

Cancer

SNIPPET

Entasis

AZ dragout Entasis; Sierra remunerates Gilead; Principia raises; Harbour BioMed and Kelun pen deal

Therapeutics

The Business Cocktail(Therapeutics)

COMMON COLD

Potential cure for Common cold

transthyretin amyloidosis

Notizia

Gilead Sciences Introduces Sovaldi: A Potent Hepatitis C Treatment

BioGen

Business Cocktail

transthyretin amyloidosis

Notizia

BioGen

Notizia

transthyretin amyloidosis

Notizia

transthyretin amyloidosis

Regeneron/Sanofi’s PD-1 drug candidate; Zika targeting drugs and vaccines developments; CMO of Achillion will leave this month; Lincoln’s anti-malarial drug

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly